share_log

Chardan Capital Maintains Buy on Coya Therapeutics, Raises Price Target to $11

Chardan Capital Maintains Buy on Coya Therapeutics, Raises Price Target to $11

Chardan Capital维持对Coya Therapeutics的买入,将目标股价上调至11美元
Benzinga ·  2023/06/08 05:20

Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and raises the price target from $9 to $11.

Chardan Capital分析师Keay Nakae维持Coya Therapeutics(纳斯达克股票代码:COYA)的买入,并将目标股价从9美元上调至11美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发